Gynecology

At the North American Menopause Society's (NAMS) 2021 Annual Meeting, sexual health specialist Michael Krychman, MD sat down with Brooke Faught, NP to learn more about the Women's Institute for Sexual Health, her role on the Planning Committee, and her tips for talking trauma with patients.

Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

The FDA has granted priority review to a supplemental biologics license application for the use of cemiplimab-rwlc in the treatment of patients with recurrent or metastatic cervical cancer whose disease progressed on, or after, chemotherapy.

New guidelines from the Centers for Disease Control and Prevention (CDC) for the screening of sexually transmitted infections (STIs) offer new ways to ask common questions.

Women who suffer from recurrent urinary tract infections (rUTIs) are typically treated with antibiotics. These treatment regimens, however, are associated with high rates of morbidity as the world faces rising antibiotic resistance.

As the COVID-19 pandemic prevails, many clinicians and patients question whether telemedicine will be the new mainstream form of health care.

Though limited data exist, Dunfaif believes there’s are indications of cardiovascular risk in patients of all ages with polycystic ovary syndrome.

A Swedish cohort study in the journal Environment International has found that women of fertile age who were exposed to high levels of perfluorinated substances (PFAS) in drinking water were significantly more likely to subsequently have a diagnosis of polycystic ovarian syndrome (PCOS) and possibly uterine leiomyoma (or uterine fibroids [UFs]), but not endometriosis.

For full-term, low-risk, nulliparous patients, induction of labor with a Foley balloon alone or concurrent with prostaglandins (PGE) is associated with a significantly lower risk of adverse neonatal outcomes than with PGE alone, according to a study in the American Journal of Perinatology.

The U.S. Food and Drug Administration (FDA) has issued 501(k) clearance for Visby Medical’s Sexual Health Click Test, a single-use, instrument-free polymerase chain reaction (PCR) diagnostic test for sexually transmitted infections (STI).

Several dietary supplements and nutrients potentially provide benefits in preventing and treating common gynecological diseases like uterine fibroids (UFs), endometriosis, polycystic ovarian syndrome (PCOS), infertility, menstrual disorders and vaginal infections, according to an article in the journal Nutrients.

The results, according to the study authors, demonstrate that screening the general population for tubal and ovarian cancer each year does not result in a survival benefit.

The American College of Obstetricians and Gynecologists (ACOG) recently published an updated committee opinion regarding morcellation of presumed uterine leiomyoma. Here are the key points.

On June 2, 2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the FDA for vulvovaginal candidiasis (VVC) in adult women and girls of reproductive age.

This list was compiled by Christine R. Isaacs, MD; and William M. Leininger, MD, as a supplement to their presentation from the 2021 American College for Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting (ACSM), held virtually April 30-May 2.

Significant updates occurred in women’s health issues while the world was in survival mode.

Pediatricians, adolescent medicine physicians, and other youth providers can play a crucial role in mitigating this risk by supporting SMGD youth and their families and promoting resilience through inclusive and clinically, culturally competent care.

The interaction of sexual orientation and provider-patient communication on sexual and reproductive health (SHR) can be tricky to navigate, according to the results of a prospective study of a sample of U.S. women of diverse sexual orientations in the journal Patient Education and Counseling.

Primary dysmenorrhea is a prevalent, underdiagnosed, but treatable condition.

A session held at the American College of Obstetricians and Gynecologists’s (ACOG) 2021 Annual Meeting highlighted the signs and obstacles when treating women and teens for PCOS.

“Researching how obesity impacts menstrual blood loss is important to improve the ways we prevent and treat the debilitating symptom of heavy menstrual bleeding,” said Jacqueline Maybin, MBChB, PhD, senior research fellow and honorary consultant gynecologist at the MRC Centre for Reproductive Health at the University of Edinburgh.

New guidance from the American College of Obstetrics and Gynecologists (ACOG) calls on ob/gyns to recognize the prevalence of trauma and its impact on patients and health care teams and outlines the importance of trauma-informed approaches to delivery of care.

Overactive bladder affects a significant portion of the overall population and has substantial impact on daily activities and quality of life.

A team of investigators has found that women with Down Syndrome received gynecologic care at lower-than-recommended rates and at substantially lower rates than other forms of health care. The investigators have called for efforts to improve gynecologic care for this vulnerable population.

The scoping review revealed target areas that require additional research, as well as a need for more variety in study designs, populations, and locations.

Initiation of more effective contraception occurred more often among patients who were seen by a volunteer reproductive health educator during routine visits at a resident obstetrics and gynecology clinic, according to a study published in Maternal and Child Health Journal.

In honor of Cervical Cancer Awareness month, Contemporary OB/GYN® will publish weekly slideshows with factual information, statistics, and more.

Diagnosis and treatment of “the great imitator” that has resurged.

“Reaching these women is critical to reduce cervical cancer rates.”

Pembrolizumab plus lenvatinib induced a statistically significant and clinically meaningful improvement in overall survival, progression-free survival, and objective response rate compared with chemotherapy in patients with advanced endometrial cancer after prior systemic therapy in the phase 3 KEYNOTE-775/Study 309 trial.